MedPath

Evaluation of the Protective Effect of Metformin against the Tamoxifen Induced Changes on Endometrium and Ovaries

Phase 3
Recruiting
Conditions
ovarian cysts.
Other and unspecified ovarian cysts
N83.2
Registration Number
IRCT20140820018866N9
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Adjutant treatment of breast cancer with tamoxifen
Normal pelvic exam
Performance state 0-2

Exclusion Criteria

Serious diseases, heart or endocrine or other systemic diseases
Use of systemic hormone therapy during past 6 months
Alcohol consumption
Diabetes
Advanced breast cancer
Having any cancer or malignancy other than breast cancer during the last three years
Atypical hypoplasia or endometrial cancer
abnormal ovarian cysts with the possibility of malignancy on ultrasound
Contraindications for using metformin (eg: allergy to biguanides, acidosis, heart disease, alcohol consumption, gastroparesis, liver disease, hyperthyroidism or hypothyroidism, severe iron deficiency anemia, renal impairment)
Unbearable and dangerous side effects of metformin (such as: abdominal pain, chest pain, chills, cholestasis, severe diarrhea, dizziness, increased liver enzymes, severe headache, hepatitis, hypoglycemia, megaloblastic anemia, myalgia, palpitations, Skin rash and rash, vomiting)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometrial thickness. Timepoint: Before and after treatment. Method of measurement: Vaginal ultrasoun.;Number and characteristic of ovarian cyst. Timepoint: Before and after treatment. Method of measurement: Vaginal ultrasound.
Secondary Outcome Measures
NameTimeMethod
Changes in liver enzymes. Timepoint: Before and after treatment. Method of measurement: laboratory test.;Chenges in weight. Timepoint: Before and after treatment. Method of measurement: Scales.;Changes in weight. Timepoint: Before and after treatment. Method of measurement: Laboratory test.
© Copyright 2025. All Rights Reserved by MedPath